 7 to 14 days in intermediate-risk patients and
for 4 to 6 weeks in high-risk patients.247 The European
Society for Vascular Surgery recommends VTE risk
assessment in all patients with consideration of individualized thromboprophylaxis (Class IIa, Level B).56
Although the weight of the evidence does suggest
some beneﬁt to pharmacological thromboprophylaxis,
the evidence is difﬁcult to generalize due